Sort   by:  
 Page size 
UnknownThe Interplay Between Age and Frailty in People Living With HIV: Results From an 11-Year Follow-up Observational Study.
Not available
S-EPMC6524826 | biostudies-literature
UnknownReduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.
Not available
S-EPMC3348954 | biostudies-literature
UnknownVisceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV.
Not available
S-EPMC5633509 | biostudies-literature
UnknownPrevalence of medication overload among older people with HIV: a MedSafer study.
Not available
S-EPMC11520045 | biostudies-literature
UnknownAdvancing integration in the approach to older adults with HIV: perspectives from geriatric and HIV specialists.
Not available
S-EPMC12739861 | biostudies-literature
UnknownPredictors of transitions in frailty severity and mortality among people aging with HIV.
Not available
S-EPMC5628822 | biostudies-literature
UnknownThe Growth Hormone Releasing Hormone Analogue, Tesamorelin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV.
Not available
S-EPMC6766405 | biostudies-literature
UnknownCorrelates of Healthy Aging in Geriatric HIV (CHANGE HIV)-CTN 314.
Not available
S-EPMC9968122 | biostudies-literature
UnknownPractical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection.
Not available
S-EPMC5411395 | biostudies-literature
UnknownDistinct Gut Microbiota Signatures Are Associated with Severity of Metabolic Dysfunction-Associated Steatotic Liver Disease in People with HIV.
Not available
S-EPMC12428781 | biostudies-literature
Sort   by:  
 Page size